Emerging Asset
Small Molecule / Peptide

GOBT-201

First-in-Class Sarcopenia Treatment

Designed by Quantum Computing to target the Apelin Pathway. GOBT-201 restores muscle mass and function by enhancing mitochondrial biogenesis in aging cells.

Quantum Designed
AI Optimized

Inquire for Co-Development


GOBT-201 Target Structure

Mechanism of Action & Efficacy

Apelin Pathway Activation & Mitochondrial Biogenesis

1. Apelin Activation

Mimics the action of Apelin, a key myokine that declines with age, activating the APJ receptor.

2. Mitochondrial Boost

Enhances mitochondrial biogenesis and function, leading to improved muscle quality and regeneration capacity.

GOBT-201 MoA and Data

Market Potential

$3.2B
Global Market Size (2028)
First
First-in-Class Opportunity

Current Status:
Discovery Phase

Join the Sarcopenia Revolution

Partner with Us

전화상담
070-4712-9090
메일문의
info@geneon.kr
KAKAO TALK
CONTACT US
▲ TOP
tel:070-4712-9090
mailto:info@geneon.kr
https://pf.kakao.com/_TWxexhs/chat
/contact-us/